Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
Sarah Jenkins(Center for Cancer Research), Alexandra S. Zimmer(Johns Hopkins University), Xiaolin Wu(Jiamusi University), Carey K. Anders(Duke University), Priscilla K. Brastianos(Massachusetts General Hospital), Oluwatobi Arisa(Center for Cancer Research), Nicole Houston(Johns Hopkins University), Cody J. Peer(National Institutes of Health), Dee Dee Smart(Center for Cancer Research), Carol Tweed(University of Maryland, Baltimore), Scott L. Carter(Broad Institute), Brett Mozarsky(Children's Hospital of Philadelphia), Darryl Nousome(University of Southern California), Tito R. Mendoza(The University of Texas MD Anderson Cancer Center), Elizabeth Vera(Center for Cancer Research), Terri S. Armstrong(The University of Texas MD Anderson Cancer Center), Patricia S. Steeg(National Cancer Institute), Imran Khan(National Institutes of Health), Seth M. Steinberg(National Institutes of Health), Stanley Lipkowitz(Center for Cancer Research), Mark R. Gilbert(Johns Hopkins University SAIS Bologna Center), Wei Zhang(Center for Cancer Research), Eric Burton(University of Missouri–Kansas City), Karen L. Smith(Merck & Co., Inc., Rahway, NJ, USA (United States)), Roisín M. Connolly(Johns Hopkins University), William D. Figg(National Cancer Institute), Ritu Shah(Center for Cancer Research)
Cited by 23
Related Papers
Comprehensive molecular profiling of lung adenocarcinoma
|Nature|2014|5.9k
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k
The Molecular Taxonomy of Primary Prostate Cancer
|Cell|2015|3.3k